Official press releases and corporate announcements for Cybin—which operates commercially under the name Helus Pharma—can be located directly on the company's dedicated investor relations web portal at ir.helus.com or its primary corporate website. Additionally, major financial market platforms, including NASDAQ, Yahoo Finance, GlobeNewswire, and Business Wire, archive all regulatory filings, clinical trial updates, financial results, and executive appointment notices issued by the company. Checking these verified channels ensures investors and researchers review authentic, up-to-date corporate communications regarding the firm's clinical pipeline progression and regulatory milestones.